Related Experiment Video
Updated: Feb 3, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
A meta-analysis on the cardiac safety profile of domperidone compared to metoclopramide
Serhat Bor1, Mesut Demir2, Oktay Ozdemir3
1Ege University School of Medicine, Division of Gastroenterology, Ege Reflux Study Group, Bornova, Izmir, Turkey.
Background:
This meta-analysis aimed to assess the cardiac safety profile of domperidone treatment for the risk of cardiovascular (CV) event and QT prolongation.
Methods:
Data from nine studies involving 101,155 patients were used for the analysis of CV event risk, while data from eight studies involving 390 patients were used for the analysis of QT prolongation risk.
Results:
Meta-analysis findings suggested a significant increase in CV risk under domperidone as compared to no treatment for domperidone doses of >30 mg/day (OR: 3.14, 95% CI, 1.191 to 8.304, p = 0.021), no significant increase in QT prolongation event rates with domperidone (3.54%, 95% CI, 1.73% to 7.10%) and a significantly lower CV risk for domperidone than for metoclopramide (OR: 0.63, 95% CI, 0.58 to 0.70, p < 0.001).
Conclusions:
The present meta-analysis indicates that domperidone treatment may not be associated with an overall CV event risk increase at doses ≤30 mg/day and does not result in QT prolongation.
More Related Videos
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
Survey Safety
Directing Effect of Substituents: meta-Directing Groups
Household Wiring And Electrical Safety
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Comparative Excretory Systems

